223 related articles for article (PubMed ID: 26043272)
1. Monoacylated Cellular Prion Proteins Reduce Amyloid-β-Induced Activation of Cytoplasmic Phospholipase A2 and Synapse Damage.
West E; Osborne C; Nolan W; Bate C
Biology (Basel); 2015 Jun; 4(2):367-82. PubMed ID: 26043272
[TBL] [Abstract][Full Text] [Related]
2. Monomeric amyloid-β reduced amyloid-β oligomer-induced synapse damage in neuronal cultures.
Bate C; Williams A
Neurobiol Dis; 2018 Mar; 111():48-58. PubMed ID: 29272738
[TBL] [Abstract][Full Text] [Related]
3. Glimepiride protects neurons against amyloid-β-induced synapse damage.
Osborne C; West E; Nolan W; McHale-Owen H; Williams A; Bate C
Neuropharmacology; 2016 Feb; 101():225-36. PubMed ID: 26432105
[TBL] [Abstract][Full Text] [Related]
4. The cellular prion protein with a monoacylated glycosylphosphatidylinositol anchor modifies cell membranes, inhibits cell signaling and reduces prion formation.
Bate C; Williams A
Prion; 2011; 5(2):65-8. PubMed ID: 21738009
[TBL] [Abstract][Full Text] [Related]
5. Sialylated glycosylphosphatidylinositols suppress the production of toxic amyloid-β oligomers.
Nolan W; McHale-Owen H; Bate C
Biochem J; 2017 Aug; 474(17):3045-3058. PubMed ID: 28729427
[TBL] [Abstract][Full Text] [Related]
6. Amyloid-β-induced synapse damage is mediated via cross-linkage of cellular prion proteins.
Bate C; Williams A
J Biol Chem; 2011 Nov; 286(44):37955-37963. PubMed ID: 21900234
[TBL] [Abstract][Full Text] [Related]
7. Amyloid-β(1-40) inhibits amyloid-β(1-42) induced activation of cytoplasmic phospholipase A2 and synapse degeneration.
Bate C; Williams A
J Alzheimers Dis; 2010; 21(3):985-93. PubMed ID: 20634578
[TBL] [Abstract][Full Text] [Related]
8. The cholesterol ester cycle regulates signalling complexes and synapse damage caused by amyloid-β.
West E; Osborne C; Bate C
J Cell Sci; 2017 Sep; 130(18):3050-3059. PubMed ID: 28760925
[TBL] [Abstract][Full Text] [Related]
9. An in vitro model for synaptic loss in neurodegenerative diseases suggests a neuroprotective role for valproic acid via inhibition of cPLA2 dependent signalling.
Williams RS; Bate C
Neuropharmacology; 2016 Feb; 101():566-75. PubMed ID: 26116815
[TBL] [Abstract][Full Text] [Related]
10. Clustering of sialylated glycosylphosphatidylinositol anchors mediates PrP-induced activation of cytoplasmic phospholipase A 2 and synapse damage.
Bate C; Williams A
Prion; 2012; 6(4):350-3. PubMed ID: 22895089
[TBL] [Abstract][Full Text] [Related]
11. Breaking the Cycle, Cholesterol Cycling, and Synapse Damage in Response to Amyloid-β.
Bate C
J Exp Neurosci; 2017; 11():1179069517733096. PubMed ID: 29238218
[TBL] [Abstract][Full Text] [Related]
12. Ethanol protects cultured neurons against amyloid-β and α-synuclein-induced synapse damage.
Bate C; Williams A
Neuropharmacology; 2011 Dec; 61(8):1406-12. PubMed ID: 21903110
[TBL] [Abstract][Full Text] [Related]
13. cAMP-Inhibits Cytoplasmic Phospholipase A₂ and Protects Neurons against Amyloid-β-Induced Synapse Damage.
Bate C; Williams A
Biology (Basel); 2015 Sep; 4(3):591-606. PubMed ID: 26389963
[TBL] [Abstract][Full Text] [Related]
14. Cellular prion protein as a therapeutic target in Alzheimer's disease.
Laurén J
J Alzheimers Dis; 2014; 38(2):227-44. PubMed ID: 23948943
[TBL] [Abstract][Full Text] [Related]
15. Does the tail wag the dog? How the structure of a glycosylphosphatidylinositol anchor affects prion formation.
Bate C; Nolan W; Williams A
Prion; 2016 Mar; 10(2):127-30. PubMed ID: 26901126
[TBL] [Abstract][Full Text] [Related]
16. α-Synuclein-induced synapse damage in cultured neurons is mediated by cholesterol-sensitive activation of cytoplasmic phospholipase A2.
Bate C; Williams A
Biomolecules; 2015 Mar; 5(1):178-93. PubMed ID: 25761116
[TBL] [Abstract][Full Text] [Related]
17. The phospholipase A
Osborne C; West E; Bate C
J Cell Sci; 2018 Apr; 131(8):. PubMed ID: 29588394
[TBL] [Abstract][Full Text] [Related]
18. Alzheimer's Aβ interacts with cellular prion protein inducing neuronal membrane damage and synaptotoxicity.
Peters C; Espinoza MP; Gallegos S; Opazo C; Aguayo LG
Neurobiol Aging; 2015 Mar; 36(3):1369-77. PubMed ID: 25599875
[TBL] [Abstract][Full Text] [Related]
19. A glycosylphosphatidylinositol analogue reduced prion-derived peptide mediated activation of cytoplasmic phospholipase A2, synapse degeneration and neuronal death.
Bate C; Tayebi M; Williams A
Neuropharmacology; 2010; 59(1-2):93-9. PubMed ID: 20398681
[TBL] [Abstract][Full Text] [Related]
20. Taxifolin prevents β-amyloid-induced impairments of synaptic formation and deficits of memory via the inhibition of cytosolic phospholipase A
Wang Y; Wang Q; Bao X; Ding Y; Shentu J; Cui W; Chen X; Wei X; Xu S
Metab Brain Dis; 2018 Aug; 33(4):1069-1079. PubMed ID: 29542038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
